Last Updated : Monday, May 13, 2019 15:28:02

Zydus Cadila gets USFDA nod to market high blood-pressure treatment drug

AHMEDABAD | MUMBAI | RAJKOT – In a press release submitted to the Stock Exchanges in India on Monday, Ahmedabad headquartered Zydus Cadila Group (Cadila Healthcare) said of having received the final approval from the USFDA (United States Food & Drugs Administration) to market Chlorthalidone Tablets USP (US RLD – THALITONE@),25 mg and 50 mg.

Chlorthalidone is used to treat high blood pressure (hypertension).

It is also used to treat fluid retention (edema) in people with congestive heart failure, cirrhosis of the liver or kidney disorders or edema caused by taking steroids or estrogen.

It will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad.

The group now has 266 approvals and has so far filed over 350 ANDAs since the commencement of the filing process in FY 2003-04.

For more details, please click the link, given here :


FacebookGoogle+LinkedinTwitterYouTube, Blogspot, Telegram, Instagram 


Do NOT follow this link or you will be banned from the site!